Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home News

Senate quietly works on bipartisan Obamacare fix as healthcare cliff nears

admin by admin
December 23, 2025
in News
0
Senate quietly works on bipartisan Obamacare fix as healthcare cliff nears
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Obamacare subsidies that have dominated the conversation on Capitol Hill are set to expire after Congress failed to act, but a cohort of bipartisan senators are quietly working to find a solution for when lawmakers return next year.

It has engulfed Congress since September and played a starring role in the longest-ever government shutdown. And both Republicans and Democrats tried, and failed, to pass their partisan plans to either extend or replace the Biden-era enhanced tax credits.

They are guaranteed to expire, and millions of Americans who use the subsidies are set to experience hikes to their out-of-pocket costs for healthcare that can vary widely depending on the state.

Still, some in Congress haven’t given up on the issue.

Sens. Susan Collins, R-Maine, and Bernie Moreno, R-Ohio, held bipartisan confabs last week as lawmakers readied to leave Washington, D.C., to hash out a framework for an Obamacare fix that could meet the desires of both sides of the aisle.

There are several political landmines that the group will have to overcome, like Democrats’ demands for a relatively clean, multiyear extension of the subsidies and Republicans’ desires to add income caps and anti-fraud measures.

‘We have some momentum to enact a bipartisan bill that includes reforms,’ Collins said. ‘As you know, Senator Moreno and I convened an ideologically diverse group of both Democratic and Republican senators who met for nearly two hours on Monday night, and we’re now working on drafting a specific bill to incorporate those conversations that will include reforms as well as the two-year extension.’

The plan has yet to see the light of day, but Collins and Moreno both already have a public proposal, as do several other lawmakers in the upper chamber.

Their original plan, released earlier this month, would extend the subsidies by two years, put an income cap onto the subsidies for households making up to $200,000 and eliminate zero-cost premiums as a fraud preventive measure by requiring a $25 minimum monthly payment.

That initial offering could give a glimpse into the final product, but there are still hurdles to getting a bill on the floor that could pass.

Namely, Senate Republicans are largely against any kind of extension to the subsidies without major reforms and a built-in off-ramp to wean off the credits, which they say are rife with fraud and funnel money directly to insurance companies rather than patients.

There’s also another wrinkle in the House, where Democrats and a handful of Republicans rebelled to force a vote on their own extension to the subsidies. That bill is expected to get a vote next month.

Lawmakers see it as changing the dynamic of negotiations in the Senate, but whether it ever makes it to a vote in the upper chamber is an open question.

‘Well, we’ll see,’ Senate Majority Leader John Thune, R-S.D., said. ‘We’ll obviously cross that bridge when we come to it.’

Some Republicans in the upper chamber see the momentum building in the House as a pressure point on them that could further drive the conversation around the subsidies and, more broadly, healthcare.

Sen. John Kennedy, R-La., said, ‘It will apply pressure on us, which isn’t a bad thing.’

‘I’m ready to start talking about healthcare at any time,’ Kennedy said. ‘I just don’t, I mean, I’m a pragmatist. I live in the real world, and I just don’t see a lot of appetite to make reforms. I just don’t — I see the vast majority of my Democratic colleagues just want an extension of the Affordable Care Act subsidies.’

And Senate Democrats welcome the development, given that the House’s plan mirrors their own, three-year extension of the subsidies, which already failed in the upper chamber earlier this month.

‘Well, it seems to me the basic proposition is, is it progress or not? And I think it is, because what we have felt all along is the only timely tool is the tax credits,’ Sen. Ron Wyden, D-Ore., said.

This post appeared first on FOX NEWS

Previous Post

Trump promises cheaper drugs under TrumpRx, but economists say the long-term costs may be hidden

Next Post

Lawmakers probe SBA loans linked to Minnesota’s $9B fraud scandal: ‘Reckless decision making’

Next Post
Epstein file drop includes ‘untrue and sensationalist claims’ about Trump, DOJ says

Epstein file drop includes ‘untrue and sensationalist claims’ about Trump, DOJ says

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
How crazy popcorn buckets became big business for movie theaters

How crazy popcorn buckets became big business for movie theaters

February 19, 2025
Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

0
Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

0
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

0
How crazy popcorn buckets became big business for movie theaters

How crazy popcorn buckets became big business for movie theaters

0
Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

December 24, 2025
GLP-1 weight-loss pills set to reshape US food demand in 2026

GLP-1 weight-loss pills set to reshape US food demand in 2026

December 24, 2025
US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

December 24, 2025
Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

December 24, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

    Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

    December 24, 2025
    GLP-1 weight-loss pills set to reshape US food demand in 2026

    GLP-1 weight-loss pills set to reshape US food demand in 2026

    December 24, 2025
    US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

    US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

    December 24, 2025
    Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

    Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

    December 24, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved